Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgical Pathology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Editorial: adrenal cortex: from physiology to disease.Front Endocrinol. 2016; 7: 1-2
- Clinical practice. The incidentally discovered adrenal mass.N Engl J Med. 2007; 356: 601-610
- Precursor lesions of the adrenal gland.Pathobiology. 2007; 74: 285-290
- Precursor lesions of endocrine system neoplasms.Pathology. 2013; 45: 316-330
- Adrenocortical carcinoma: review and update.Adv Anat Pathol. 2014; 21: 151-159
- Adrenal cortical proliferations.in: Mete O. Asa S.L. Endocrine pathology. Cambridge University Press, United Kingdom2016: 602-627
- Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.J Clin Endocrinol Metab. 2008; 93: 3266-3281
- Update in primary aldosteronism.J Clin Endocrinol Metab. 2015; 100: 1-10
- Clinicopathologic correlates of primary aldosteronism.Arch Pathol Lab Med. 2015; 139: 948-954
- Clinicopathological correlates of adrenal Cushing’s syndrome.J Clin Pathol. 2015; 68: 175-186
- Congenital adrenal hyperplasia.Lancet. 2017; 390: 2194-2210
- The adrenal cortex.in: Stefaneanu L. Sasano H. Kovacs K. Molecular and Cellular Endocrine Pathology. Arnold, London2000: 221-252
- Management of the clinically inapparent adrenal mass (‘incidentaloma’).Ann Intern Med. 2003; 138: 424-429
- Distinguishing benign from malignant adrenal masses.Cancer Imaging. 2003; 3: 102-110
- Diagnostic imaging of the thyroid and adrenal glands in childhood.Endocrinol Metab Clin North Am. 2005; 34: 745-768
- CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism.J Comput Assist Tomogr. 1991; 15: 773-779
- Hormonal, radiological, NP-59 scintigraphy, and pathological correlations in patients with cushing’s syndrome due to primary pigmented nodular adrenocortical disease (PPNAD).J Clin Endocrinol Metab. 2015; 100: 4332-4338
- The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.J Clin Endocrinol Metab. 2009; 94: 2406-2413
- Targeted molecular imaging in adrenal disease-an emerging role for metomidate PET-CT.Diagnostics (Basel). 2016; 6 ([pii:E42])
- 11 C-Metomidate PET/CT is a useful adjunct for lateralisation of primary aldosteronism in routine clinical practice.Clin Endocrinol (Oxf). 2019; https://doi.org/10.1111/cen.13942
- Imaging of adrenal incidentalomas: current status.AJR Am J Roentgenol. 2002; 179: 559-568
- Adrenal imaging.in: Hodler J. Kubik-Huch R.A. von Schulthess G.K. Diseases of the abdomen and pelvis 2018-2021. Springer International Publishing, Cham (Switzerland)2018: 85-90
- Laparoscopic surgery for malignant adrenal tumors.JSLS. 2009; 13: 196-202
- A diagnostic approach to adrenal cortical lesions.Endocr Pathol. 2008; 19: 241-251
- Morphological distinction of cortisol-producing and aldosterone-producing adrenal cortical adenomas: not only possible but a critical clinical responsibility.Histopathology. 2012; 60 ([author reply: 1016–7]): 1015-1016
- Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors.Am J Surg Pathol. 2002; 26: 1612-1619
- WHO classification of tumours of endocrine organs.4th edition. WHO Press, Lyon (France)2017
- The many faces of primary aldosteronism and cushing syndrome: a reflection of adrenocortical tumor heterogeneity.Front Med. 2018; 5: 54
- Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.Diagn Pathol. 2014; 9: 147
- Cushing syndrome in carney complex: clinical, pathologic, and molecular genetic findings in the 17 affected mayo clinic patients.Am J Surg Pathol. 2017; 41: 171-181
- Genetics of adrenal tumors associated with Cushing’s syndrome: a new classification for bilateral adrenocortical hyperplasias.Nat Clin Pract Endocrinol Metab. 2007; 3: 748-757
- Carney complex with adrenal cortical carcinoma.J Clin Endocrinol Metab. 2012; 97: E202-E206
- A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.J Clin Endocrinol Metab. 2012; 97: 351-359
- Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.Am J Surg Pathol. 2011; 35: 1882-1893
- Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.Mod Pathol. 2018; 31: 1708-1716
- Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors.Am J Surg Pathol. 1984; 8: 163-169
- Pathologic features of prognostic significance in adrenocortical carcinoma.Am J Surg Pathol. 1989; 13: 202-206
- Adrenocortical oncocytic tumors: report of 10 cases and review of the literature.Int J Surg Pathol. 2004; 12: 231-243
- Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.Histopathology. 2009; 55: 535-543
- The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.Am J Surg Pathol. 2013; 37: 1433-1440
- Diagnostic and prognostic biomarkers of adrenal cortical carcinoma.Am J Surg Pathol. 2018; 42: 201-213
- Diagnosis of adrenocortical tumors by reticulin algorithm.Indian J Endocrinol Metab. 2017; 21: 734-737
- Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.Am J Surg Pathol. 2010; 34: 973-983
- Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas.Endocr J. 2008; 55: 49-55
- Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.Hum Pathol. 2015; 46: 404-410
- Validation of the prognostic role of the ‘Helsinki Score’ in 225 cases of adrenocortical carcinoma.Hum Pathol. 2017; 62: 1-7
- Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors.Front Endocrinol. 2015; 6: 1-9
- Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients.Am J Surg Pathol. 2003; 27: 867-881
- Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review.Mod Pathol. 2018; https://doi.org/10.1038/s41379-018-0174-8
- Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?.J Pediatr Surg. 2016; 51: 1795-1800
- Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.Pediatr Surg Int. 2015; 31: 563-571
- Immunohistochemical biomarkers of adrenal cortical neoplasms.Endocr Pathol. 2018; 29: 137-149
- Comprehensive pan-genomic characterization of adrenocortical carcinoma.Cancer Cell. 2016; 29: 723-736
- Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.Langenbecks Arch Surg. 2010; 395: 955-961
- Prognostic parameters of metastatic adrenocortical carcinoma.J Clin Endocrinol Metab. 2007; 92: 148-154
- The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma.Am J Surg Pathol. 2011; 35: 471-473
- Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.Hum Pathol. 2015; 46: 1799-1807
- Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.Hum Pathol. 2016; 58: 113-122
- IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.Histopathology. 2006; 49: 298-307
- p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.J Clin Endocrinol Metab. 1994; 78: 790-794
- Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children’s oncology group study.J Clin Oncol. 2015; 33: 602-609
- Clinical impact of TP53 alterations in adrenocortical carcinomas.Langenbecks Arch Surg. 2012; 397: 209-216
- Management of endocrine disease: adrenocortical carcinoma: differentiating the good from the poor prognosis tumors.Eur J Endocrinol. 2018; 178: R215-R230
- Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.J Clin Oncol. 2009; 27: 1108-1115
- Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.Clin Cancer Res. 2009; 15: 668-676
- Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.Mod Pathol. 2014; 27: 1246-1254
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.Eur J Endocrinol. 2018; 179: G1-G46
- An international Ki67 reproducibility study in adrenal cortical carcinoma.Am J Surg Pathol. 2016; 40: 569-576
- Automated Selection of Hotspots (ASH): enhanced automated segmentation and adaptive step finding for Ki67 hotspot detection in adrenal cortical cancer.Diagn Pathol. 2014; 9: 216
- Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.J Clin Endocrinol Metab. 2015; 100: 841-849
- Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.Hum Pathol. 2016; 53: 41-50
- Altered telomeres in tumors with ATRX and DAXX mutations.Science. 2011; 333: 425
- Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.J Clin Pathol. 2014; 67: 968-973
- Immunohistochemistry of the adrenal in primary aldosteronism.Curr Opin Endocrinol Diabetes Obes. 2016; 23: 242-248
- Histopathological classification of cross-sectional image-negative hyperaldosteronism.J Clin Endocrinol Metab. 2017; 102: 1182-1192
- Adrenal lesion in multiple endocrine neoplasia type 1.Surgery. 1995; 118: 1077-1082
- High frequency of germline p53 mutations in childhood adrenocortical cancer.J Natl Cancer Inst. 1994; 86: 1707-1710
- Adrenal masses are associated with familial adenomatous polyposis.Dis Colon Rectum. 2000; 43: 1739-1742
- Adrenocortical carcinoma is a lynch syndrome-associated cancer.J Clin Oncol. 2013; 31: 3012-3018
- Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.Eur J Endocrinol. 2017; 177: 439-444
- Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis.Endocrinol Diabetes Metab Case Rep. 2014; 2014: 140074
- Molecular definition of the 11p15.5 region involved in Beckwith-Wiedemann syndrome and probably in predisposition to adrenocortical carcinoma.Hum Genet. 1989; 81: 273-277
- Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals.J Endocr Soc. 2017; 1: 787-799
- Cellular and genetic causes of idiopathic hyperaldosteronism.Hypertension. 2018; 72: 874-880
- Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.Mol Cell Endocrinol. 2015; 399: 311-320
- Intracellular molecular differences in aldosterone- compared to cortisol-secreting adrenal cortical adenomas.Front Endocrinol. 2016; 7: 75
- Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.PLoS One. 2012; 7: e41926
- Aldosterone-producing adenomas: histopathology-genotype correlation and identification of a novel CACNA1D mutation.Hypertension. 2017; 70: 129-136
- Molecular heterogeneity in aldosterone-producing adenomas.J Clin Endocrinol Metab. 2016; 101: 999-1007
- A genetic and molecular update on adrenocortical causes of Cushing syndrome.Nat Rev Endocrinol. 2016; 12: 255-262
- Activating PRKACB somatic mutation in cortisol-producing adenomas.JCI Insight. 2018; 3
- Carney complex.Exp Clin Endocrinol Diabetes. 2019; 127: 156-164
- Alterations of Phosphodiesterases in Adrenocortical Tumors.Front Endocrinol. 2016; 7: 111
- ARMC5 mutations in macronodular adrenal hyperplasia with Cushing’s syndrome.N Engl J Med. 2013; 369: 2105-2114
- A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1.Endocr J. 2011; 58: 269-277
- Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.Clin Cancer Res. 2008; 14: 4016-4024
- Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation.J Clin Endocrinol Metab. 2005; 90: 3773-3779
- Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.J Clin Endocrinol Metab. 2009; 94: 2930-2937
- Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.Clin Cancer Res. 2010; 16: 5133-5141
- Genomic landscape of paediatric adrenocortical tumours.Nat Commun. 2015; 6: 6302
- Integrated genomic characterization of adrenocortical carcinoma.Nat Genet. 2014; 46: 607-612
- Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.J Clin Endocrinol Metab. 2015; 100: E493-E502
- Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors.Nat Commun. 2018; 9: 4172
- Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma.Clin Cancer Res. 2019; 25: 3276-3288
- Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients.Eur J Endocrinol. 2012; 166: 61-67
Article info
Publication history
Published online: September 27, 2019
Footnotes
Disclosure: The authors have nothing to disclose.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
